Gavi Current Affairs - 2020

India to supply Pneumonia Vaccine to low-income nations

The Pune based Serum Institute of India is to supply Pneumonia vaccine to low-income countries. The Institute is one of the leading manufacturers of vaccines and immunobiological drugs.

Highlights

The Serum Institute of India and UNICEF have signed an agreement to supply pneumonia vaccine to low income countries. Under the agreement, the institutes are to provide 10 million Pneumococcal Conjugate Vaccine that will help prevent pneumonia to low income countries every year

The Pune based Serum Institute of India is to supply Pneumonia vaccine to low-income countries. The Institute is one of the leading manufacturers of vaccines and immunobiological drugs.

Highlights

The Serum Institute of India and UNICEF have signed an agreement to supply pneumonia vaccine to low income countries. Under the agreement, the institutes are to provide 10 million Pneumococcal Conjugate Vaccine that will help prevent pneumonia to low income countries every year.

GAVI Alliance

The Serum Institute of India along with UNICEF and GAVI alliance are to supply the vaccine at 2 USD per does. This is 43% less than GAVI price of 3.50 USD under the Advance Market Commitment

Advance Market Commitment

Under Advance Market Commitment, the GAVI alliance provided incentives to the pharmaceutical companies to develop and produce suitable vaccines. This was done to provide sustainable prices to the vaccines.

The AMC was launched in 2009. It has so far prevented deaths of 700,000 children in 60 developing countries. The AMC programme is set to end this year (2020). The programme was launched by Canada, UK, Russia, Bill and Melinda Gates Foundation and Norway.

Background

Pneumonia is the biggest killer of children in the world that takes the life of a child every 39 seconds.

GAVI Alliance

The Serum Institute of India along with UNICEF and GAVI alliance are to supply the vaccine at 2 USD per does. This is 43% less than GAVI price of 3.50 USD under the Advance Market Commitment

Advance Market Commitment

Under Advance Market Commitment, the GAVI alliance provided incentives to the pharmaceutical companies to develop and produce suitable vaccines. This was done to provide sustainable prices to the vaccines.

The AMC was launched in 2009. It has so far prevented deaths of 700,000 children in 60 developing countries. The AMC programme is set to end this year (2020). The programme was launched by Canada, UK, Russia, Bill and Melinda Gates Foundation and Norway.

Background

Pneumonia is the biggest killer of children in the world that takes the life of a child every 39 seconds.

GAVI Alliance: India pledges 15 million USD

On June 4, 2020, PM Modi participated at the Global Vaccine Summit that was led by the United Kingdom. At the summit, the prime minster announced that India will pledge 15 million USD to GAVI Alliance.

Highlights

The world leaders have come together to find a vaccine to the COVID-19 with GAVI as an integrating platform. The Global Vaccine Summit organized by UK discussed on collecting funds for GAVI. Over 50 countries participated in the programme.

India at GAVI

India has now become a big supporter of the alliance. This saved GAVI 400 million USD in the past five years. Earlier India was only a beneficiary. Since 2014, India had become a donor. Till date India has donated 12 million USD to the Alliance.

PM Modi at the Summit

PM Modi highlighted the following at the summit

  • India shared its medicines to more than 120 countries.
  • India understands the importance of immunization. India has so far added six vaccines to its National Immunization Programme.
  • India has digitized the vaccine supply chain
  • The cold supply chain of the vaccines in India is being monitored by electronic intelligence network